1. Home
  2. INUV vs AYTU Comparison

INUV vs AYTU Comparison

Compare INUV & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$1.45

Market Cap

24.2M

ML Signal

HOLD

Logo Aytu BioPharma Inc.

AYTU

Aytu BioPharma Inc.

HOLD

Current Price

$2.21

Market Cap

27.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INUV
AYTU
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.2M
27.4M
IPO Year
1996
2015

Fundamental Metrics

Financial Performance
Metric
INUV
AYTU
Price
$1.45
$2.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$11.00
$9.33
AVG Volume (30 Days)
192.9K
40.3K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
N/A
EPS
0.13
N/A
Revenue
$86,209,305.00
$27,632,080.00
Revenue This Year
N/A
N/A
Revenue Next Year
$12.89
$43.75
P/E Ratio
$11.08
N/A
Revenue Growth
2.88
277.47
52 Week Low
$1.31
$1.65
52 Week High
$6.27
$3.07

Technical Indicators

Market Signals
Indicator
INUV
AYTU
Relative Strength Index (RSI) 38.82 42.64
Support Level $1.33 $2.17
Resistance Level $1.70 $2.30
Average True Range (ATR) 0.09 0.10
MACD 0.00 0.02
Stochastic Oscillator 27.89 41.94

Price Performance

Historical Comparison
INUV
AYTU

About INUV Inuvo Inc.

Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.

Share on Social Networks: